Targeted Therapies for Solid Tumors

A Handbook for Moving Toward New Frontiers in Cancer Treatment
Buch | Hardcover
269 Seiten
2015 | 2015 ed.
Humana Press Inc. (Verlag)
978-1-4939-2046-4 (ISBN)

Lese- und Medienproben

Targeted Therapies for Solid Tumors -
106,99 inkl. MwSt
This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections of the book have been structured to review the oncogene addicted tumors, the pharmacology and clinical development of new molecularly targeted agents, the use of biomarkers as prognostic, predictive and surrogate endpoints, and the evaluation of tumor response and specific malignancies treated with targeted agents. The book also covers some of the newest developments in cancer therapy that are not adequately covered by any current available literature.

Written by recognized experts in the field, Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer Treatment provides a unique and valuable resource in the field of molecular oncology, both for those currently in training, and for those already in clinical or research practice.

Antonio Russo, MD, PhD University of Palermo, Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, Palermo, Italy Rafael Rosell, MD, PhD Hospital Germans Trias i Pujol, Catalan Institute of Oncology, Director, Cancer Biology & Precision Medicine Program, Badalona, Barcelona, Spain Christian Rolfo, MD, PhD Antwerp University Hospital, Phase I - Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp, Edegem, Antwerpen, Belgium

Introduction.- Oncogene Addiction in Solid Tumors.- Pharmacology and Clinical Development of New Molecularly Targeted Agents.- Biomarkers as Prognostic, Predictive and Surrogate Endpoints.- Evaluation of Response in Malignant Tumors Treated with Targeted Agents.- Targeted Therapies for HER2-Positive Breast Cancer.- Role of PARP Inhibitors in Triple Negative Breast Cancer (TNBC).- Targeted Therapies in Squamous Cell Carcinoma of the Head and Neck.- Targeted Therapies for NSCLC.- Targeted Therapies for Gastric Cancer.- Targeted Therapies for Pancreatic Cancer.- Targeted Therapies in Hepatocellular Carcinoma.- Targeted Therapies for Colorectal Cancer.- Targeted Therapy in Gastrointestinal Stromal Tumors.- Targeted Therapies in Kidney Cancer.- Targeted Therapies in Melanoma.- Targeted Therapies for Prostate Cancer.- Targeted Therapies for Bone Metastases.

Reihe/Serie Current Clinical Pathology
Zusatzinfo 23 Illustrations, color; 6 Illustrations, black and white; X, 269 p. 29 illus., 23 illus. in color.
Verlagsort Totowa, NJ
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Pathologie
ISBN-10 1-4939-2046-4 / 1493920464
ISBN-13 978-1-4939-2046-4 / 9781493920464
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gerald Höfler; Hans Kreipe; Holger Moch

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
104,00

von Thomas Kirchner; Hans Konrad Müller-Hermelink …

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
42,00
Klinisch-pathologische Übersichtskarten

von Thomas Cerny; Kirill Karlin

Buch | Hardcover (2023)
Springer (Verlag)
34,99